Natural Health Tip – Diversify
in Asian Kempo and More
By Gary Scott
Financial benefits are not the only thing coming out of the
East. Nor is diversification just for wealth. Spreading out in health issues
is called cross training. Cross training Chinese and Indian knowledge can help
us support our livers. Our livers are under attack from all types of toxicities,
pesticides to preservatives, that human bodies never had to cope with until
this generation. The liver is such a vital organ that it is wise to take digestive
enzymes and nutrients that nourish it.
This is why Merri and I use the first blend that uses ancient
healing sciences from China and India to help the liver. We not selling or
profiting from this product…which is what I want to add up front. We
just use it, Dr. Burgstiner’s Liver C/S Plus sold by Preventive Therapeutics,
Inc.
This is the first formulation combined from the ancient
knowledge of traditional Chinese and Ayurvedic liver herbs. This
is a synergistic blend of herbs and nutrients designed to cleanse and support
the liver and encourage regeneration of liver tissue. This formula contains
Alpha Lipoic Acid, Phosphatidyl Choline, Inositol, Milk thistle Seed, Tumeric,
Dandelion, Artichoke, Schizandra, Bluperum, Organic liver extract, Andrographis
Paniculata, Picorhiza Kurroa, Phyllantrus Amrus and Bioperine Black Pepper
fruit extract.
We are also told by the people at Preventive Therapeitics,
Inc. that many users of Liver C/S Plus who have hepatitis problems are doing
well and when they take this formula.
There is more on this subject of the liver from Japan as well!
A July 2003 daily message at our site said, “We saw yesterday that the
wellness industry is growing in two sectors. These sectors are the natural
and scientific. In the scientific field, some of the fast growing sectors are
cosmetic plastic surgery, cosmetic dermatology (such as botox) voluntary eye
surgery, (such as lasik, etc.), genetic engineering (sex selection and fertility
enhancement), cosmetic and reconstructive dentistry, and voluntary pharmaceuticals
(Viagra, Rogaine) etc.
“The natural industry (which is the place where Merri
and I fit) includes health care and nutritional education, food supplements,
vitamins and minerals, preventative medicine, wellness insurance, fitness clubs,
trainers, coaches, fitness equipment, health foods, health food restaurants
and weight loss products.
Often the proponents of these two sectors are at odds (we
are of course are on the natural side), but each sector is huge and growing
and already represents 200 billion a year in sales (half the sale of automobiles).”
Now the natural side is growing so fast that the scientific
side is getting involved.
Take for example Sho saiko-to, a Japanese liver support. An
article in Natural Standard says, “Sho saiko-to, a Japanese herbal formula
that is a part of the East Asian Chinese medicine tradition, called Kampo.
A Kampo drug is a standardized and regulated multi-herb formula. Kampo formulas
are an essential component of Japanese integrative medicine and are often given
to patients alongside Western treatments in even the most mainstream of Japan’s
hospitals.
“Researchers at Memorial Sloan-Kettering Cancer Center
in New York are conducting a clinical phase II trial to determine whether sho-saiko-to
(SST) can help treat Hepatitis C (HCV). An estimated five million Americans
have been infected with HCV, according to new research presented at the American
Association for the Study of Liver Diseases Conference in November 2005.
“Most of the patients in the clinical trial have a genotype
1 infection, which is less responsive to conventional treatment than the other
five genotypes. Of the 31 patients in the study, 15 have already completed
the daily regimen of 7.5g of sho-saiko-to granules (4.2g of standardized herbal
extract) for 52 weeks. Researchers reported the preliminary results of the
15 patients at the second Society
of Integrative Oncology Conference in San Diego last November.
“So far the study, titled ‘Sho-saiko-to for Patients
with Chronic Hepatitis C Who Are Intolerant to or Have Contraindication to
Interferon-Based Therapy: A Phase II Study,’ has shown promising results.
“Among the 15 patients who completed the study, 11 patients
showed reductions in alanine aminotransferase (ALT) and 10 patients showed
reductions in aspartate aminotransferase (AST). Patients with hepatitis typically
have high levels of both enzymes. No serious side effects have been attributed
to sho-saiko-to among any patients enrolled in the trial.
“The results are consistent with previous Japanese clinical
trials, which found that SST has anti- inflammatory effects. In animal studies,
SST has demonstrated anti-fibrotic effects by inhibition of lipid peroxidation
in liver cells and stellate cells. It has also been shown to reduce the incidence
of liver cancer in patients with hepatitis and liver cirrhosis.” You
can read the entire article at www.naturalstandard.com.
Gary
June, 2006
Back to top of page
|